1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY: Epidemic obesity and type 2 diabetes in Asia. LANCET 2006, 368(9548):1681-1688.
2. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014, 2(8):634-647.
3. Seuring T, Archangelidi O, Suhrcke M: The Economic Costs of Type 2 Diabetes: A Global Systematic Review. PHARMACOECONOMICS 2015, 33(8):811-831.
4. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(1):4-14.
5. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. LANCET 2016, 387(10027):1513-1530.
6. Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D et al: Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA 2017, 317(24):2515-2523.
7. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. ANN INTERN MED 1990, 113(12):909-915.
8. Defronzo RA: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. DIABETES 2009, 58(4):773-795.
9. Scheen AJ: Pathophysiology of type 2 diabetes. ACTA CLIN BELG 2003, 58(6):335-341.
10. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237(3):E214-E223.
11. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, Jacques-Camarena O, Rodriguez-Moran M: The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010, 95(7):3347-3351.
12. Abbasi F, Reaven GM: Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides x glucose versus triglyceride/high-density lipoprotein cholesterol. METABOLISM 2011, 60(12):1673-1676.
13. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F: The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008, 6(4):299-304.
14. Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B: TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011, 93(3):e98-e100.
15. Guerrero-Romero F, Villalobos-Molina R, Jimenez-Flores JR, Simental-Mendia LE, Mendez-Cruz R, Murguia-Romero M, Rodriguez-Moran M: Fasting Triglycerides and Glucose Index as a Diagnostic Test for Insulin Resistance in Young Adults. ARCH MED RES 2016, 47(5):382-387.
16. Mazidi M, Kengne AP, Katsiki N, Mikhailidis DP, Banach M: Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complications 2018, 32(3):266-270.
17. Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, Li L, Zhang L, Ren Y, Zhao Y et al: Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. CARDIOVASC DIABETOL 2017, 16(1):30.
18. Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, Lee JH, Yim HW, Kang MI, Lee WC et al: Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLOS ONE 2014, 9(2):e90430.
19. Lee JW, Lim NK, Park HY: The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans. BMC ENDOCR DISORD 2018, 18(1):33.
20. Low S, Khoo K, Irwan B, Sum CF, Subramaniam T, Lim SC, Wong T: The role of triglyceride glucose index in development of Type 2 diabetes mellitus. Diabetes Res Clin Pract 2018, 143:43-49.
21. Park B, Lee HS, Lee YJ: Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. TRANSL RES 2021, 228:42-51.
22. Ke P, Wu X, Xu M, Feng J, Xu H, Gan Y, Wang C, Deng Z, Liu X, Fu W et al: Comparison of obesity indices and triglyceride glucose-related parameters to predict type 2 diabetes mellitus among normal-weight elderly in China. Eat Weight Disord 2021.
23. Chen Y, Zhang XP, Yuan J, Cai B, Wang XL, Wu XL, Zhang YH, Zhang XY, Yin T, Zhu XH et al: Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ OPEN 2018, 8(9):e21768.
24. White IR, Royston P, Wood AM: Multiple imputation using chained equations: Issues and guidance for practice. STAT MED 2011, 30(4):377-399.
25. Zheng Y, Ley SH, Hu FB: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. NAT REV ENDOCRINOL 2018, 14(2):88-98.
26. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. DIABETOLOGIA 2003, 46(1):3-19.
27. Alejandro EU, Gregg B, Blandino-Rosano M, Cras-Meneur C, Bernal-Mizrachi E: Natural history of beta-cell adaptation and failure in type 2 diabetes. MOL ASPECTS MED 2015, 42:19-41.
28. Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM: Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. INT J ENDOCRINOL 2012, 2012:983814.
29. Ferrara D, Montecucco F, Dallegri F, Carbone F: Impact of different ectopic fat depots on cardiovascular and metabolic diseases. J CELL PHYSIOL 2019, 234(12):21630-21641.
30. Pranata R, Huang I, Irvan, Lim MA, Vania R: The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus-a systematic review and dose-response meta-analysis of cohort studies. ENDOCRINE 2021.
31. Samuel VT, Shulman GI: The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J CLIN INVEST 2016, 126(1):12-22.
32. Morino K, Petersen KF, Shulman GI: Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. DIABETES 2006, 55 Suppl 2:S9-S15.
33. Liu EQ, Weng YP, Zhou AM, Zeng CL: Association between Triglyceride-Glucose Index and Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study. BIOMED RES INT 2020, 2020:2947067.
34. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI et al: Type 2 diabetes mellitus. NAT REV DIS PRIMERS 2015, 1:15019.
35. Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X: Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. CARDIOVASC DIABETOL 2014, 13:146.
36. Wang B, Zhang M, Liu Y, Sun X, Zhang L, Wang C, Li L, Ren Y, Han C, Zhao Y et al: Utility of three novel insulin resistance-related lipid indices for predicting type 2 diabetes mellitus among people with normal fasting glucose in rural China. J DIABETES 2018, 10(8):641-652.
37. Navarro-Gonzalez D, Sanchez-Inigo L, Pastrana-Delgado J, Fernandez-Montero A, Martinez JA: Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. PREV MED 2016, 86:99-105.
38. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. DIABETES 1995, 44(8):863-870.
39. Robertson RP, Harmon J, Tran PO, Poitout V: Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. DIABETES 2004, 53 Suppl 1:S119-S124.
40. Janghorbani M, Almasi SZ, Amini M: The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction. ACTA DIABETOL 2015, 52(4):781-788.
41. Trouwborst I, Bowser SM, Goossens GH, Blaak EE: Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions. Front Nutr 2018, 5:77.